JLL bids C$229m for drug company Patheon
The private equity firm, formerly called Joseph Littlejohn & Levy, holds a 30% stake in the Canadian company.
12 January 2013•1 min read
The private equity firm, formerly called Joseph Littlejohn & Levy, holds a 30% stake in the Canadian company.
